Total Joint Arthroplasty in a Pediatric Population

Launched by UNIVERSITY OF COLORADO, DENVER · Mar 3, 2020

Keywords

ClinConnect Summary

This clinical trial is looking at how total joint arthroplasty (TJA) surgery affects the way young people function in their daily lives and their overall quality of life. Specifically, the study focuses on patients aged 10 to 25 who have undergone this surgery for reasons not related to tumors in the joint. By understanding the experiences of these patients, the researchers hope to gain insights that can improve care for future patients.

To participate in the trial, individuals must be between the ages of 10 and 25 and have received TJA surgery at Children's Hospital Colorado, either from specific doctors or under certain non-tumor-related conditions. Those who have had certain other surgeries or specific medical conditions may not be eligible. Participants will be asked to share information about their health and well-being through simple questionnaires, which will help researchers assess the impact of TJA on their lives. Overall, this study aims to gather valuable information that can enhance treatment and support for young patients undergoing joint surgeries.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: Populations 1,2,3
• • Age between 10 years and 25 years
• • Undergoing or have undergone total joint arthroplasty at Children's Hospital Colorado for non-solid tumor related reasons
• • Treated at Children's Hospital Colorado by Dr. Nathan Donaldson, DO or Dr. Steven Thorpe, MD or previously by Travis Heare, MD
• • Exclusion Criteria: Populations 1,2,3
• • Subjects and/or parents not capable of completing basic questionnaires in English (HRQL data will not be collected from non-English speaking subjects because we do not have access to versions of these questionnaires that have been validated in languages other than English. These patients may be included at a later date when validated questionnaires are available).
• • Subjects who underwent hemiarthroplasties, failed rotationplasty to arthroplasty conversions, or joint arthroplasty directly related to a tumor at the location of the joint
• • Subjects diagnosed with mucopolysaccharidoses (MPS), pseudorheumatoid chondrodysplasia, or diastrophic dwarfism
• • Inclusion Criteria: Population 4
• • Age between 10 years and 25 years
• • Treated at Children's Hospital Colorado by Dr. Nathan Donaldson, DO, or Dr. Steven Thorpe, MD or previously by Travis Heare, MD
• • Symptomatic joint pain treated non-invasively via lifestyle modifications, over the counter or prescription pain medication, nerve blocks or steroid injections, and/or physical therapy
• • Symptomatic joint pain treated via core decompression surgery at Children's Hospital Colorado by Dr. Nathan Donaldson, DO, or Dr. Steven Thorpe, MD, or previously by Travis Heare, MD
• • Exclusion Criteria: Population 4
• • Patients who underwent a joint arthroplasty directly related to a tumor at the location of the joint at Children's Hospital Colorado. Patients undergoing or have undergone total joint arthroplasty at Children's Hospital Colorado for non-solid tumor related reasons
• • Subjects diagnosed with mucopolysaccharidoses (MPS), pseudorheumatoid chondrodysplasia, or diastrophic dwarfism